United States· US:52389-242_2d7c94e6-382b-1655-e063-6394a90a712d
Nauzene
A medicinal product containing trisodium citrate dihydrate, registered in United States by Kobayashi Healthcare International, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRISODIUM CITRATE DIHYDRATE
- Manufacturer
- Kobayashi Healthcare International, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1152389-242-10
- ndc1152389-242-42
- ndc1152389-242-56
- ndc1152389242101 BLISTER PACK in 1 CARTON (52389-242-10) / 10 TABLET, CHEWABLE in 1 BLISTER PACK
- ndc1152389242423 BLISTER PACK in 1 CARTON (52389-242-42) / 14 TABLET, CHEWABLE in 1 BLISTER PACK
- ndc1152389242564 BLISTER PACK in 1 CARTON (52389-242-56) / 14 TABLET, CHEWABLE in 1 BLISTER PACK
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trisodium citrate dihydrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCIGENTAFresenius Medical Care Deutschland GmbH, Bad Homburg
- BelgiumCivastyn 136 mmol/lFresenius Medical Care Deutschland
- FinlandCifobanFresenius Medical Care Deutschland GmbH
- United KingdomSoltran solution 1litre Viaflex bagsBaxter Healthcare Ltd
- IrelandCifoban 136 mmol/l solution for infusionFresenius Medical Care Deutschland GmbH
- NetherlandsCifoban 136 mmol/l oplossing voor infusieFresenius Medical Care Deutschland GmbH
- CanadaANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USPBAXTER CORPORATION
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Canesoasis Cystitis Relief, Care Cystitis Relief
- Italy · Sodio Citrato S.A.L.F.
- Portugal · Citrato De Sódio 3,8%, Citrato De Sódio 5,0%
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/928b7dc6-b84a-4963-99f9-e49418e097bc GET /v1/drugs/928b7dc6-b84a-4963-99f9-e49418e097bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "230",
"substance": "TRISODIUM CITRATE DIHYDRATE",
"productndc": "52389-242",
"dosage_form": "TABLET, CHEWABLE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "M001",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about trisodium citrate dihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.